Bliss GVS Pharma informs about disclosure

22 Mar 2022 Evaluate

Bliss GVS Pharma has informed that the exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti V Rao & Vibha G Sharma.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

103.40 -0.95 (-0.91%)
29-May-2024 15:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1477.40
Dr. Reddys Lab 5994.20
Cipla 1493.00
Zydus Lifesciences 1045.40
Lupin 1601.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.